Chief Scientific Officer @ Critical Outcome Technologies, Inc. (May 2017 - December 2017)
Chair of Scientific Advisory Board @ (January 2014 - December 2016)
Exec VP, Research and Development @ (September 2011 - December 2013)
Senior Medical Director @ Entelos (September 2008 - May 2011)
Principal @ Rosa & Co. (January 2007 - September 2008)
Director, Disease Simulation at PRD and ALZA @ (January 2005 - January 2007)
Head, Medical Informatics @ (January 1998 - January 2005)
Medical Fellow @ R.W. Johnson PRI (January 1997 - January 1998)
Rheumatology Fellow @ Yale Univ School of Medicine (January 1995 - January 1997)
Internal Medicine Resident @ Yale Univ School of Medicine (January 1992 - January 1995)
Richard Ho Education
Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo
MD-PhD (immunopharmacology)
1984-1992
Harvard University
A.B. (physics)
1980-1984
Portsmouth HS
Richard Ho Skills
Lifesciences
Clinical Trials
Informatics
Medicine
Immunology
Pharmaceutical Industry
Internal Medicine
Drug Discovery
Biotechnology
Cancer
R&D
Clinical Development
Drug Development
Mathematical Modeling
Oncology
Public Speaking
Sales
Advisory
Microsoft Office
Marketing
Microsoft Excel
Research
Personalized Medicine
Richard Ho Summary
Richard Ho, based in United States, is currently a Chief Technology Officer at Amaro Therapeutics, Inc.. Richard Ho brings experience from previous roles at Cotinga Pharmaceuticals, Critical Outcome Technologies, Inc. and Marina Biotech, Inc.. Richard Ho holds a 1984 - 1992 MD-PhD in immunopharmacology @ Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo. With a robust skill set that includes Lifesciences, Clinical Trials, Informatics, Medicine, Immunology and more. Richard Ho has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Richard Ho?
Find contact details for 700 million professionals.